How much did Sensorion achieve in EBIT for the current year?
In the current year, Sensorion has achieved an EBIT of -26.05 M EUR.
Sensorion EBIT 2025
Sensorion EBIT
-26.05 M EUR
Ticker
ALSEN.PA
ISIN
FR0012596468
WKN
A14SVV
In 2025, Sensorion's EBIT was -26.05 M EUR, a -8.28% increase from the -28.4 M EUR EBIT recorded in the previous year.
The Sensorion EBIT history
| YEAR | EBIT (M EUR) |
|---|---|
| 2030e | - |
| 2029e | - |
| 2028e | 50.99 |
| 2027e | -15.25 |
| 2026e | -14.92 |
| 2025e | -26.05 |
| 2024 | -28.4 |
| 2023 | -22.31 |
| 2022 | -23.14 |
| 2021 | -15.02 |
| 2020 | -8.89 |
| 2019 | -10.81 |
| 2018 | -12.23 |
| 2017 | -9.52 |
| 2016 | -8.42 |
| 2015 | -4.75 |
| 2014 | -2.86 |
| 2013 | -1.49 |
| 2012 | -0.97 |
Sensorion Revenue, EBIT, Net Income
3 years
5 years
10 years
25 Years
Max
Loading chart...
Revenue
EBIT
Net Income
Details
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Sensorion, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sensorion from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sensorion’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Sensorion. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Sensorion’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Sensorion’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sensorion’s growth potential.
Sensorion Revenue, EBIT and net profit per share
| Date | Sensorion Revenue | Sensorion EBIT | Sensorion Net Income |
|---|---|---|---|
| 2030e | 198.8 M undefined | 0 undefined | 103.16 M undefined |
| 2029e | 182.36 M undefined | 0 undefined | 100.21 M undefined |
| 2028e | 151.47 M undefined | 50.99 M undefined | 88.42 M undefined |
| 2027e | 20.61 M undefined | -15.25 M undefined | -13.16 M undefined |
| 2026e | 24.96 M undefined | -14.92 M undefined | -11.7 M undefined |
| 2025e | 15.72 M undefined | -26.05 M undefined | -24.13 M undefined |
| 2024 | 0 undefined | -28.4 M undefined | -25.97 M undefined |
| 2023 | 0 undefined | -22.31 M undefined | -22.06 M undefined |
| 2022 | 0 undefined | -23.14 M undefined | -23.21 M undefined |
| 2021 | 0 undefined | -15.02 M undefined | -15.14 M undefined |
| 2020 | 0 undefined | -8.89 M undefined | -8.98 M undefined |
| 2019 | 0 undefined | -10.81 M undefined | -12.1 M undefined |
| 2018 | 0 undefined | -12.23 M undefined | -12.35 M undefined |
| 2017 | 0 undefined | -9.52 M undefined | -9.69 M undefined |
| 2016 | 0 undefined | -8.42 M undefined | -8.83 M undefined |
| 2015 | 0 undefined | -4.75 M undefined | -4.83 M undefined |
| 2014 | 0 undefined | -2.86 M undefined | -3.08 M undefined |
| 2013 | 0 undefined | -1.49 M undefined | -1.65 M undefined |
| 2012 | 0 undefined | -970,000 undefined | -990,000 undefined |
Sensorion stock margins
The Sensorion margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sensorion. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sensorion.
3 years
5 years
10 years
25 Years
Max
Loading chart...
Gross margin
EBIT margin
Profit margin
Details
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Sensorion's sales revenue. A higher gross margin percentage indicates that the Sensorion retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Sensorion's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Sensorion's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sensorion's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sensorion. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sensorion's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Sensorion Margin History
| Sensorion Gross margin | Sensorion Profit margin | Sensorion EBIT margin | Sensorion Profit margin |
|---|---|---|---|
| 2030e | 0 % | 0 % | 51.89 % |
| 2029e | 0 % | 0 % | 54.95 % |
| 2028e | 0 % | 33.66 % | 58.37 % |
| 2027e | 0 % | -73.99 % | -63.86 % |
| 2026e | 0 % | -59.79 % | -46.87 % |
| 2025e | 0 % | -165.7 % | -153.5 % |
| 2024 | 0 % | 0 % | 0 % |
| 2023 | 0 % | 0 % | 0 % |
| 2022 | 0 % | 0 % | 0 % |
| 2021 | 0 % | 0 % | 0 % |
| 2020 | 0 % | 0 % | 0 % |
| 2019 | 0 % | 0 % | 0 % |
| 2018 | 0 % | 0 % | 0 % |
| 2017 | 0 % | 0 % | 0 % |
| 2016 | 0 % | 0 % | 0 % |
| 2015 | 0 % | 0 % | 0 % |
| 2014 | 0 % | 0 % | 0 % |
| 2013 | 0 % | 0 % | 0 % |
| 2012 | 0 % | 0 % | 0 % |
Sensorion Aktienanalyse
What does Sensorion do?
The company Sensorion SA is a French biotechnology company that specializes in developing innovative therapies for hearing and balance disorders. It was founded in 2009 and is headquartered in Montpellier. Sensorion SA's business model is based on researching and developing new drugs that can be used to treat inner ear diseases. These diseases often have severe effects on the quality of life and social interaction of those affected and represent a significant unmet medical need. Sensorion SA aims to develop innovative and effective therapies to address this need. The company specializes in two main areas: hearing disorders and balance disorders. In the field of hearing disorders, Sensorion SA focuses on developing drugs to treat sensorineural hearing loss. These disorders can be caused by various factors such as aging, noise exposure, or genetic predisposition and affect the inner ear. Sensorion SA has a promising pipeline of drugs in clinical development based on different mechanisms of action. These drugs aim to protect the inner ear and restore hearing function. In the field of balance disorders, Sensorion SA focuses on developing new drugs to treat dizziness and vestibular disorders. These disorders can be caused by factors such as aging, medications, or neurological diseases and affect the balance system in the inner ear. Sensorion SA also has a promising pipeline of drugs in clinical development in this area. Sensorion SA's products are not yet available on the market as they are still in development and undergoing clinical trials. However, the company works closely with academic and industry partners to test and validate its drugs. The development of new drugs is a lengthy and costly process that can take many years. However, Sensorion SA is confident that its therapies have the potential to improve the lives of many people. Overall, Sensorion SA has a promising business model based on the development of innovative therapies for hearing and balance disorders. The company has a promising pipeline of drugs in clinical development and works closely with partners to test and validate its products. If successful, their drugs could have a significant impact on the lives of people suffering from these diseases. Sensorion ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Sensorion's EBIT
Sensorion's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Sensorion's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Sensorion's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Sensorion’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Sensorion stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Sensorion.
How has the EBIT of Sensorion developed in recent years?
The EBIT of Sensorion has increased by -8.282% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Sensorion?
The EBIT of Sensorion is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Sensorion pay?
Over the past 12 months, Sensorion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensorion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Sensorion?
The current dividend yield of Sensorion is .
When does Sensorion pay dividends?
Sensorion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Sensorion?
Sensorion paid dividends every year for the past 0 years.
What is the dividend of Sensorion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Sensorion located?
Sensorion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sensorion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sensorion from 10/20/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/20/2025.
When did Sensorion pay the last dividend?
The last dividend was paid out on 10/20/2025.
What was the dividend of Sensorion in the year 2024?
In the year 2024, Sensorion distributed 0 EUR as dividends.
In which currency does Sensorion pay out the dividend?
The dividends of Sensorion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Sensorion
Our stock analysis for Sensorion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensorion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
